Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ankri

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
American Heart Journal|December 1, 1990
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteriesG Montalescot, G Drobinski, J Maclouf, et al.
International Journal of Cardiology|August 8, 1997
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery diseaseG Montalescot, A Ankri, B Chadefaux-Vekemans, et al.
Bone Marrow Transplantation|April 1, 1993
Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patientsV Leblond, B D Salehian, C Borel, et al.
Circulation|November 1, 1991
Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectorisG Montalescot, G Drobinski, J Maclouf, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1993
[Effects of ultrasonic energy on blood clots in vitro]G Drobinski, F Philippe, C Bucherer, et al.
Journal of the American College of Cardiology|July 18, 2000
Effects of various anticoagulant treatments on von Willebrand factor release in unstable anginaG Montalescot, J P Collet, L Lison, et al.
Circulation|July 14, 2004
Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparinG Montalescot, J P Collet, M L Tanguy, et al.
Journal of Inherited Metabolic Disease|December 31, 1998
Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?L Thuillier, B Chadefaux-Vekemans, J P Bonnefont, et al.
American Heart Journal|April 13, 2004
Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromesJ P Collet, G Montalescot, J L Golmard, et al.
Annals of Internal Medicine|April 15, 2000
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisoloneN Costedoat-Chalumeau, Z Amoura, G Aymard, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
American Heart Journal|December 1, 1990
Early thromboxane release during pacing-induced myocardial ischemia with angiographically normal coronary arteriesG Montalescot, G Drobinski, J Maclouf, et al.
International Journal of Cardiology|August 8, 1997
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery diseaseG Montalescot, A Ankri, B Chadefaux-Vekemans, et al.
Bone Marrow Transplantation|April 1, 1993
Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patientsV Leblond, B D Salehian, C Borel, et al.
Circulation|November 1, 1991
Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectorisG Montalescot, G Drobinski, J Maclouf, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1993
[Effects of ultrasonic energy on blood clots in vitro]G Drobinski, F Philippe, C Bucherer, et al.
Journal of the American College of Cardiology|July 18, 2000
Effects of various anticoagulant treatments on von Willebrand factor release in unstable anginaG Montalescot, J P Collet, L Lison, et al.
Circulation|July 14, 2004
Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparinG Montalescot, J P Collet, M L Tanguy, et al.
Journal of Inherited Metabolic Disease|December 31, 1998
Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease?L Thuillier, B Chadefaux-Vekemans, J P Bonnefont, et al.
American Heart Journal|April 13, 2004
Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromesJ P Collet, G Montalescot, J L Golmard, et al.
Annals of Internal Medicine|April 15, 2000
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisoloneN Costedoat-Chalumeau, Z Amoura, G Aymard, et al.
Pageof 6